World Health Organisation, 2021, Available at: https://www.who.int/news-room/fact-sheets/detail/cancer . Accessed November 2021.

Cancer Research UK, Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer#heading-Zero. Accessed November 2021.

The Royal College of Radiologists

Postoperative radiotherapy for breast cancer: UK consensus statements.

Clinical Oncol. November 2016; (Available at:) (Accessed November 2021)

Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: breast radiotherapy practice in the UK.

Clin. Oncol. 2021; 33: 419-426https://doi.org/10.1016/j.clon.2021.01.012Bjerregaard Stick L Laugaard Lorenzen E Svitzer Yates E et al.

Selection criteria for early breast cancer patients in the DBCG proton trial—The randomised phase III trial strategy.

Clin. Transl. Radiat. Oncol. 2021; 27: 126-131https://doi.org/10.1016/j.ctro.2021.01.012Ranger A Dunlop A Hutchinson K et al.

A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain.

Clin. Oncol. 2018; 30: 346-353https://doi.org/10.1016/j.clon.2018.01.017Cozzi L Lohr F Fogliata A et al.

Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer.

Radiat. Oncol. 2017; 12: 200https://doi.org/10.1186/s13014-017-0935-4Virén T Heikkilä J Myllyoja K et al.

Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy.

Radiat. Oncol. 2015; 10: 79https://doi.org/10.1186/s13014-015-0392-xSeppälä J Vuolukka K Viréa T et al.

Breast deformation during the course of radiotherapy: The need for an additional outer margin.

Physica. Medica. 2019; 65: 1-5https://doi.org/10.1016/j.ejmp.2019.07.021Tyran M Tallet A Resbeut M et al.

Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy.

J. Appl. Clin. Med. Phys. 2018; 19: 463-472https://doi.org/10.1002/acm2.12398Nicolini G Fogliata A Clivio A et al.

Planning strategies in volumetric modulated arc therapy for breast.

Med. Phys. 2011; 38: 4025-4031https://doi.org/10.1118/1.3598442

The effect of optimization on surface dose in intensity modulated radiotherapy (IMRT).

Phys. Med. Biol. 2004; 49: 4919-4928https://doi.org/10.1088/0031-9155/49/21/005Thilmann C Grosser KH Rhein B et al.

Virtual bolus for inversion radiotherapy planning in intensity-modulated radiotherapy of breast carcinoma within the scope of adjuvant therapy.

Strahlenther. Onkol. 2002; 178: 139-146https://doi.org/10.1007/s00066-002-0915-xJensen CA Acosta Roa AM Johansena M et al.

Robustness of VMAT and 3DCRT plans toward setup errors in radiation therapy of locally advanced left-sided breast cancer with DIBH.

Physica. Medica. 2018; 45: 12-18https://doi.org/10.1016/j.ejmp.2017.11.019Dunlop A Colgan R Kirby A et al.

Evaluation of organ motion-based robust optimization for VMAT planning for breast and internal mammary chain radiotherapy.

Clin. Transl. Radiat. Oncol. 2019; 16: 60-66https://doi.org/10.1016/j.ctro.2019.04.004Van der Veen GJ Janssen T Duijn A.

A robust volumetric arc therapy planning approach for breast cancer involving the axillary nodes.

Medical Dosimetry. 2019; 44: 183-189https://doi.org/10.1016/j.meddos.2018.06.001

National Institute for Health Research NIHR funding and awards search website (2020). Available at: https://fundingawards.nihr.ac.uk/award/NIHR131120. Accessed March, 2022

Offersen BV Boersma LJ Kirkove C et al.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

Radiother. Oncol. 2015; 114: 3-10https://doi.org/10.1016/j.radonc.2014.11.030Brunt AM Haviland JS Wheatley DA et al.

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

Lancet. 2020; 395: 1613-1626https://doi.org/10.1016/S0140-6736(20)30932-6Jain P Marchant T Green M et al.

Inter-fraction motion and dosimetric consequences during breast intensity-modulated radiotherapy (IMRT).

Radiother. Oncol. 2009; 90: 93-98https://doi.org/10.1016/j.radonc.2008.10.010Michalski A Atyeo J Cox J et al.

Inter- and intra-fraction motion during radiation therapy to the whole breast in the supine position: a systematic re-view.

J. Med. Imaging Radiat. Oncol. 2021; 56: 499-509https://doi.org/10.1111/j.1754-9485.2012.02434.xCrama K Brondijk E Visser J et al.

Can underdosage due to breast swelling be mitigated with robust optimization for breast radiotherapy.

Radiother. Oncol. 2020; 152: S1039-S1040https://doi.org/10.1016/S0167-8140(21)01882-XLiang X Bradley JA Mailhot Vega RB et al.

Using robust optimization for skin flashing in intensity modulated radiation therapy for breast cancer treatment: A feasibility study.

Pract. Radiat. Oncol. 2020; 10: 59-69https://doi.org/10.1016/j.prro.2019.09.017Dunlop A McQuaid D Nill S et al.

Comparison of CT number calibration techniques for CBCT-based dose calculation.

Strahlenther. Onkol. 2015; 191: 970-978https://doi.org/10.1007/s00066-015-0890-7Sarkar B Tharmarnadar G Anusheel M et al.

In regards to Bogue J, Wan J, Lavey RS, Parsai EI. Dosimetric comparison of VMAT with integrated skin flash to 3D field-in-field tangents for left breast irradiation.

J. Appl. Clin. Med. Phys. 2019; 20: 24-29https://doi.org/10.1002/acm2.12607